{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:14:34Z","timestamp":1788621274947,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trim.2026.102431","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:29:20Z","timestamp":1787585360000},"page":"102431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of adding umbilical cord blood derived stem cells to haploidentical stem cell transplant (haplo-cord) on post-transplant survival and graft-versus-host disease in patients with hematological malignancies: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"98","author":[{"given":"Muhammad Zain","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2179-1300","authenticated-orcid":false,"given":"Anas","family":"Babar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad Ehsan","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musab","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ahmad","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102431_bb0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbmt.2007.12.493","article-title":"Lifetime probabilities of hematopoietic stem cell transplantation in the US","volume":"14","author":"Nietfeld","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jtct.2023.08.028","article-title":"Overcoming barriers to autologous stem cell transplantation in multiple myeloma: recommendations from a multidisciplinary roundtable discussion","volume":"29","author":"Bashir","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41409-021-01274-1","article-title":"Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality","volume":"56","author":"Ramdial","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02983793","article-title":"The pathophysiology of acute graft-versus-host disease","volume":"78","author":"Ferrara","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.trim.2026.102431_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trim.2026.102431_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5030035","article-title":"Role of \u03b1\u03b2 T cell depletion in prevention of graft versus host disease","volume":"5","author":"Abdelhakim","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.trim.2026.102431_bb0040","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1080\/1042819031000083019","article-title":"CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation","volume":"44","author":"BUTT","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102431_bb0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2017.22","article-title":"Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future","volume":"52","author":"Saad","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/stcltm\/szac086","article-title":"Umbilical cord blood transplantation: connecting its origin to its future","volume":"12","author":"Sanchez-Petitto","year":"2023","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.trim.2026.102431_bb0055","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/bmt.2013.48","article-title":"Characteristics of chronic GvHD after cord blood transplantation","volume":"48","author":"Newell","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0060","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2026.102431_bb0065","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.trim.2026.102431_bb0070","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","article-title":"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia","volume":"97","author":"Rocha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102431_bb0075","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3324\/haematol.2012.079244","article-title":"Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function","volume":"98","author":"Romero-Moya","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.trim.2026.102431_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000010327","article-title":"Variability in CD34+ cell counts in umbilical cord blood: implications for cord blood transplants","volume":"50","author":"Yap","year":"2000","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.trim.2026.102431_bb0085","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3324\/haematol.2014.109280","article-title":"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen","volume":"99","author":"Ruggeri","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.trim.2026.102431_bb0090","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2017.05.004","article-title":"Umbilical cord blood transplantation without antithymocyte globulin results in similar survival but better quality of life compared with unrelated peripheral blood stem cell transplantation for the treatment of acute leukemia\u2014a retrospective study in China","volume":"23","author":"Tong","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.seminhematol.2016.07.004","article-title":"Haploidentical cord transplantation\u2014the best of both worlds","volume":"53","author":"van Besien","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.trim.2026.102431_bb0100","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1080\/10428194.2024.2361353","article-title":"Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. \u2013 a review of techniques and analysis of outcomes","volume":"65","author":"van Besien","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102431_bb0105","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/S2352-3026(24)00372-7","article-title":"Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial","volume":"12","author":"Yu","year":"2025","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.trim.2026.102431_bb0110","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jtct.2021.12.010","article-title":"Clinical outcomes of B cell acute lymphoblastic leukemia patients treated with haploidentical stem cells combined with umbilical cord blood transplantation","volume":"28","author":"Zhou","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0115","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbmt.2017.12.794","article-title":"Reduced-intensity allogeneic transplant for acute myeloid leukemia and myelodysplastic syndrome using combined CD34-selected haploidentical graft and a single umbilical cord unit compared with matched unrelated donor stem cells in older adults","volume":"24","author":"Tsai","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-024-01820-5","article-title":"Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial","volume":"9","author":"Zhou","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0125","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41409-019-0666-2","article-title":"Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia","volume":"55","author":"Xu","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/10428194.2019.1695053","article-title":"Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation","volume":"61","author":"Lyu","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102431_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s13287-022-03170-x","article-title":"Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation","volume":"13","author":"Yang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/bmt.2017.36","article-title":"Haplo-cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML","volume":"52","author":"Kwon","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0145","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/bloodadvances.2019000200","article-title":"Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning","volume":"3","author":"van Besien","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2026.102431_bb0150","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41409-024-02335-x","article-title":"Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study","volume":"59","author":"Zhu","year":"2024","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/bmt.2017.229","article-title":"Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients","volume":"53","author":"Ke","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0160","doi-asserted-by":"crossref","first-page":"849.e1","DOI":"10.1016\/j.jtct.2022.08.025","article-title":"Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow grafts","volume":"28","author":"Huang","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720964771","article-title":"Haploidentical hematopoietic stem cell transplantation versus umbilical cord blood transplantation in hematologic malignancies: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbmt.2006.12.035","article-title":"32: single versus double umbilical cord blood transplantation (UCBT): higher risk of acute graft-versus-host disease (GvHD) but lower transplant related mortality (TRM) in recipients of double UCBT","volume":"13","author":"MacMillan","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13287-023-03538-7","article-title":"A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation","volume":"14","author":"Tu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.trim.2026.102431_bb0180","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3109\/10428194.2012.739688","article-title":"Immune reconstitution after combined haploidentical and umbilical cord blood transplant","volume":"54","author":"Jain","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102431_bb0185","doi-asserted-by":"crossref","DOI":"10.21037\/sci.2017.05.03","article-title":"Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications","volume":"4","author":"Servais","year":"2017","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.trim.2026.102431_bb0190","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood-2011-10-384057","article-title":"Induction of acute GvHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic\u2013derived antigen-presenting cells","volume":"119","author":"Toubai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102431_bb0195","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI61019","article-title":"Antigen-presenting cell-derived complement modulates graft-versus-host disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trim.2026.102431_bb0200","article-title":"Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults","volume":"6","author":"Chakupurakal","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.trim.2026.102431_bb0205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bmt.2013.154","article-title":"Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study","volume":"49","author":"Chen","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbmt.2018.09.002","article-title":"Cord Haploidentical non-in vitro T cell depletion allogeneic hematopoietic stem cell transplantation reduces relapse of refractory acute leukemia","volume":"25","author":"Wang","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0215","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.4049\/jimmunol.174.8.4706","article-title":"Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10highIL-12absent dendritic cells with tolerogenic potential","volume":"174","author":"Li","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2026.102431_bb0220","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trim.2026.102431_bb0225","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/ajt.16970","article-title":"Cross-decoration of dendritic cells by non-inherited maternal antigen-containing extracellular vesicles: potential mechanism for PD-L1-based tolerance in cord blood and organ transplantation","volume":"22","author":"Lema","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0230","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.trim.2026.102431_bb0235","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1432-2277.2006.00304.x","article-title":"The influence of inherited and noninherited parental antigens on outcome after transplantation","volume":"19","author":"Van Den Boogaardt","year":"2006","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2026.102431_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1311436","article-title":"Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant","volume":"6","author":"Kanaan","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trim.2026.102431_bb0245","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1119541109","article-title":"Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation","volume":"109","author":"van Rood","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.trim.2026.102431_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2015.00093","article-title":"Cord blood as a source of natural killer cells","volume":"2","author":"Mehta","year":"2016","journal-title":"Front. Med."},{"key":"10.1016\/j.trim.2026.102431_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1621260","article-title":"Cord blood-derived iNK T cells as a platform for allogeneic CAR T cell therapy","volume":"16","author":"Grefe","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102431_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071777","article-title":"KIR receptors as key regulators of NK cells activity in health and disease","volume":"10","author":"D\u0119bska-Zielkowska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.trim.2026.102431_bb0265","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1357-4310(99)01451-3","article-title":"HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story","volume":"5","author":"Hicklin","year":"1999","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.trim.2026.102431_bb0270","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2008.365","article-title":"KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia","volume":"23","author":"Willemze","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2026.102431_bb0275","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41467-018-02911-y","article-title":"CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells","volume":"9","author":"Oleinika","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trim.2026.102431_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10428190009087014","article-title":"Th2 and Tc2 cells in the regulation of GvHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma","volume":"38","author":"Fowler","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102431_bb0285","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1158\/1078-0432.CCR-20-0305","article-title":"The role of antigen spreading in the efficacy of immunotherapies","volume":"26","author":"Brossart","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trim.2026.102431_bb0290","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8+ T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2026.102431_bb0295","first-page":"560","article-title":"Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia","volume":"20","author":"Harris","year":"1994","journal-title":"Blood Cells"},{"key":"10.1016\/j.trim.2026.102431_bb0300","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1182\/bloodadvances.2024013117","article-title":"NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation","volume":"8","author":"Sch\u00e4fer","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2026.102431_bb0305","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2026.102431_bb0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/sci.2017.05.09","article-title":"Graft predominance after double umbilical cord blood transplantation: a review","volume":"4","author":"Cornelissen","year":"2017","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.trim.2026.102431_bb0315","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/bmt.2017.102","article-title":"Against the odds: haplo-cord grafts protect from GvHD and relapse","volume":"52","author":"Choe","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102431_bb0320","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20002.1","article-title":"Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation","volume":"8","author":"Huang","year":"2019","journal-title":"F1000Res"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:54:54Z","timestamp":1788620094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S0966327426000894"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102431","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of adding umbilical cord blood derived stem cells to haploidentical stem cell transplant (haplo-cord) on post-transplant survival and graft-versus-host disease in patients with hematological malignancies: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102431"}}